Skip to main content
. 2021 Jun 23;95(1135):20210295. doi: 10.1259/bjr.20210295

Figure 3.

Figure 3.

(a) and b) Comparison of dose and dose-volume parameters of the OAR of the DIBH and FB plans in the patients treated with (n = 26) or without RNI (n = 71) a) Dmean of the heart and the LAD b) Dose parameters of other OAR